Arrow Mark Colorado Holdings LLC Oric Pharmaceuticals, Inc. Transaction History

Arrow Mark Colorado Holdings LLC

$4.67 Billion
Q3 2025

A detailed history of Arrow Mark Colorado Holdings LLC transactions in Oric Pharmaceuticals, Inc. stock. As of the latest transaction made, Arrow Mark Colorado Holdings LLC holds 1,097,497 shares of ORIC stock, worth $14.4 Million. This represents 0.28% of its overall portfolio holdings.

Number of Shares

1,097,497

Previous 1,278,454 14.15%

Holding current value

$14.4 Million

Previous $13 Million 0.9%

% of portfolio

0.28%

Previous 0.26%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	SELL	$9.2 - $11.93 $1.66 Million - $2.16 Million	-180,957 Reduced 14.15%	1,097,497 $13.1 Million
Q2 2025 Aug 14, 2025	SELL	$4.26 - $10.55 $288,551 - $714,604	-67,735 Reduced 5.03%	1,278,454 $13 Million
Q1 2025 May 15, 2025	SELL	$5.58 - $12.54 $274,329 - $616,504	-49,163 Reduced 3.52%	1,346,189 $7.51 Million
Q4 2024 Feb 14, 2025	BUY	$7.68 - $10.3 $313,681 - $420,693	40,844 Added 3.02%	1,395,352 $11.3 Million
Q3 2024 Nov 14, 2024	BUY	$7.52 - $11.9 $609,014 - $963,733	80,986 Added 6.36%	1,354,508 $13.9 Million

Q2 2024 Aug 14, 2024	SELL	$6.63 - $12.93 $1.57 Million - $3.07 Million	-237,339 Reduced 15.71%	1,273,522 $9 Million
Q1 2024 May 15, 2024	SELL	$8.04 - $16.03 $1.79 Million - $3.57 Million	-222,958 Reduced 12.86%	1,510,861 $20.8 Million
Q4 2023 Feb 14, 2024	BUY	$5.41 - $9.43 $1.71 Million - $2.98 Million	315,946 Added 22.28%	1,733,819 $16 Million
Q2 2023 Aug 14, 2023	BUY	$4.95 - $8.4 $5.75 Million - $9.76 Million	1,162,141 Added 454.44%	1,417,873 $11 Million
Q1 2023 May 15, 2023	SELL	$4.26 - $6.75 $1.14 Million - $1.81 Million	-267,426 Reduced 51.12%	255,732 $1.46 Million
Q4 2022 Feb 14, 2023	SELL	$2.41 - $5.89 $49,776 - $121,652	-20,654 Reduced 3.8%	523,158 $3.08 Million
Q3 2022 Nov 14, 2022	SELL	$3.15 - $5.24 $2.33 Million - $3.87 Million	-739,346 Reduced 57.62%	543,812 $1.74 Million
Q1 2022 May 16, 2022	SELL	$4.54 - $16.1 $2.8 Million - $9.92 Million	-616,233 Reduced 32.44%	1,283,158 $6.85 Million
Q4 2021 Feb 14, 2022	BUY	$12.01 - $20.3 $7.8 Million - $13.2 Million	649,684 Added 51.99%	1,899,391 $27.9 Million
Q3 2021 Nov 15, 2021	BUY	$15.9 - $25.22 $3.62 Million - $5.75 Million	227,809 Added 22.29%	1,249,707 $26.1 Million
Q2 2021 Aug 16, 2021	SELL	$17.37 - $25.34 $84,852 - $123,785	-4,885 Reduced 0.48%	1,021,898 $18.1 Million
Q1 2021 May 17, 2021	SELL	$23.67 - $36.85 $617,692 - $961,637	-26,096 Reduced 2.48%	1,026,783 $25.2 Million
Q4 2020 Feb 16, 2021	BUY	$20.32 - $39.8 $1.17 Million - $2.29 Million	57,497 Added 5.78%	1,052,879 $35.6 Million
Q3 2020 Nov 16, 2020	BUY	$19.5 - $31.26 $14.3 Million - $22.9 Million	733,604 Added 280.24%	995,382 $24.9 Million
Q2 2020 Aug 14, 2020	BUY	$25.68 - $38.12 $6.72 Million - $9.98 Million	261,778 New	261,778 $8.83 Million

Others Institutions Holding ORIC

# of Institutions

157

Shares Held

105M

Call Options Held

35.1K

Put Options Held

173K

View Full List

About Oric Pharmaceuticals, Inc.

Ticker ORIC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,576,700
Market Cap $518M
Description
ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment r...

More about ORIC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Arrow Mark Colorado Holdings LLC, based on Form 13F filings with the SEC.

News

Stay updated on Arrow Mark Colorado Holdings LLC with notifications on news.

Account

Arrow Mark Colorado Holdings LLC Oric Pharmaceuticals, Inc. Transaction History